[go: up one dir, main page]

MX2009013022A - Formulaciones de n-(2-acetil-4,6-dimetilfenil)-3-{[3,4-dimetil-5-i soxazolil)amino]sulfonil}-2-tiofenocarboxamida. - Google Patents

Formulaciones de n-(2-acetil-4,6-dimetilfenil)-3-{[3,4-dimetil-5-i soxazolil)amino]sulfonil}-2-tiofenocarboxamida.

Info

Publication number
MX2009013022A
MX2009013022A MX2009013022A MX2009013022A MX2009013022A MX 2009013022 A MX2009013022 A MX 2009013022A MX 2009013022 A MX2009013022 A MX 2009013022A MX 2009013022 A MX2009013022 A MX 2009013022A MX 2009013022 A MX2009013022 A MX 2009013022A
Authority
MX
Mexico
Prior art keywords
formulations
thiophenecarboxamide
dimethylphenyl
isoxazolyl
sulfonyl
Prior art date
Application number
MX2009013022A
Other languages
English (en)
Inventor
Jinling Chen
Lian Rajewski
Aaron Schoeneman
Andrew Trammel
Kent Amsberry
Original Assignee
Encysive Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Encysive Pharmaceuticals Inc filed Critical Encysive Pharmaceuticals Inc
Publication of MX2009013022A publication Critical patent/MX2009013022A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

En la presente invención se proporcionan formulaciones intravenosas y orales de N-(2-acetil-46-dimetilfenil)-3-{[3,4-dime til-5-isoxazolil)amino]sulfonil}-2-tiofenocarboxamida. También se proporcionan procedimientos para elaborar y usar las formulaciones.
MX2009013022A 2007-06-25 2008-06-24 Formulaciones de n-(2-acetil-4,6-dimetilfenil)-3-{[3,4-dimetil-5-i soxazolil)amino]sulfonil}-2-tiofenocarboxamida. MX2009013022A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93721507P 2007-06-25 2007-06-25
PCT/US2008/007836 WO2009002490A2 (en) 2007-06-25 2008-06-24 Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide

Publications (1)

Publication Number Publication Date
MX2009013022A true MX2009013022A (es) 2010-01-20

Family

ID=39720482

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009013022A MX2009013022A (es) 2007-06-25 2008-06-24 Formulaciones de n-(2-acetil-4,6-dimetilfenil)-3-{[3,4-dimetil-5-i soxazolil)amino]sulfonil}-2-tiofenocarboxamida.

Country Status (12)

Country Link
US (1) US20080317858A1 (es)
EP (1) EP2170278A2 (es)
JP (1) JP2010531357A (es)
KR (1) KR20100032863A (es)
CN (1) CN102137655A (es)
AU (1) AU2008269149A1 (es)
BR (1) BRPI0812966A2 (es)
CA (1) CA2689048A1 (es)
IL (1) IL202513A0 (es)
MX (1) MX2009013022A (es)
RU (1) RU2009146836A (es)
WO (1) WO2009002490A2 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
CN1414965A (zh) * 1999-12-31 2003-04-30 德州生物科技公司 调整内皮肽活性的磺酰胺及其衍生物
CA2415697A1 (en) * 2000-07-13 2002-01-24 James C. Forbes Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
US20030198666A1 (en) * 2002-01-07 2003-10-23 Richat Abbas Oral insulin therapy
WO2008019072A2 (en) * 2006-08-04 2008-02-14 Encysive Pharmaceuticals, Inc. Polymorphs of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-thiophene-carboxamide
WO2008060890A2 (en) * 2006-11-09 2008-05-22 Gilead Colorado, Inc. Darusentan oral dosage form

Also Published As

Publication number Publication date
WO2009002490A2 (en) 2008-12-31
AU2008269149A1 (en) 2008-12-31
IL202513A0 (en) 2010-06-30
EP2170278A2 (en) 2010-04-07
CA2689048A1 (en) 2008-12-31
WO2009002490A3 (en) 2010-04-08
CN102137655A (zh) 2011-07-27
JP2010531357A (ja) 2010-09-24
BRPI0812966A2 (pt) 2017-05-16
US20080317858A1 (en) 2008-12-25
RU2009146836A (ru) 2011-07-27
KR20100032863A (ko) 2010-03-26

Similar Documents

Publication Publication Date Title
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
UA96449C2 (en) Stable laquinimod preparations
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
EA200701065A1 (ru) Инъецируемые составы, содержащие нанодисперсный оланзапин
MX2009002666A (es) Compuestos de n-metilaminometil isoindol, composiciones que los comprenden y metodos que utilizan los mismos.
TW200700406A (en) Novel thiophene derivatives
TW200716591A (en) Novel thiophene derivatives
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
IL193024A0 (en) Levetiracetam formulations and methods for their manufacture
TW200708511A (en) Novel thiophene derivatives
TW200716552A (en) Novel thiophene derivatives
TW200700086A (en) Injectable non-aqueous suspension
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
TW200505875A (en) Novel compounds
EA201170703A1 (ru) Производные адамантилбензамида
TW200738670A (en) Novel thiophene derivatives
TW200716628A (en) Novel compounds
TW200626132A (en) Topical nepafenac formulations
MX2009011319A (es) Adenosina desaminasa recombinante estable.
TW200716204A (en) Pharmaceutical composition
MEP34308A (en) Oral formulations of cladribine
TW200738649A (en) Calcilytic compounds
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
ZA200604874B (en) Pharmaceutical compositions
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal